[1]王学文.ADAMTS13和血栓症[J].医学研究与战创伤救治(原医学研究生学报),2009,11(03):230-234.

点击复制

ADAMTS13和血栓症()

分享到62.8K

参考文献/References:

[1] Levy GG,Nichols WC,Lian EC,et al.Mutations in a member of the ADAMTS13 gene family cause thrombotic thrombocytopenic purpura[J].Nature,2001,413 (6855):488-494.
[2] Zheng X, Chung D, Takayama TK, et al. Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura[J].J Biol Chem,2001,276(44):41059-41163.
[3] George JN.Thrombotic thrombocytopenic purpura[J].N Engl J Med,2006,354(18):1927-1935.
[4] Moake JL.Thrombotic microangiopathies[J].N Engl J Med,2002,347(8):589-600.
[5] Fujimura Y,Matsumoto M,Yagi H,et al.von Willebrand factor-cleaving protease and Upshaw-Schulman syndrome[J].Int J Hematol,2002,75(1):25-34.
[6] 王学文.血栓性血小板减少性紫癜-溶血性尿毒症综合征的发病机制和病理生理学进展[J].诊断学理论与实践,2006,5(2):175-179.
[7] 王学文.血栓性血小板减少性紫癜的发病机理和诊断及治疗进展[J].东南国防医药,2004,6(3):238-240.
[8] Doldan-Silvero A , Acevedo-Gadea C,Habib C,et al.ADAMTS13 activity and inhibitor[J].Am J Hematol,2008,83(10):811-814.
[9] Dong L,Chandrasekaran V, Zhou W, et al.Evolution of ADAMTS13 antibodies in a fatal case of thrombotic thromcytopenic purpura[J].Am J Hematol,2008,83 (10):815-817.
[10] Ann Knovich M,Lawson HL,Burke HM,et al.Rapid quantitative assay of ADAMTS13 activity on an automated coagulation analyzer:Clinical applications and comparison with immunoblot method[J].Am J Hematol,2008,83(8):654-656.
[11] 藤村吉博.TTPとHUS[J].医学のぁゅみ，2003，206(1):101-104.
[12] 松本雅则，八木秀男，藤村吉博. vWF-cleaning protease/ADAMTS-13[J].臨床血液，2003，44(3):60-68.
[13] Doldan-Silvero A,Acevedo-Gadea C, Habib C,et al.ADAMTS13 activity and inhibitor[J].Am J Hematol,2008,83(10):811-814.
[14] Uemura M,Tatsumi K,Matsumoto M,et al.Localization of ADAMTS13 to the stellate cells of human liver[J].Blood,2005,106(3):922-924.
[15] Amitrano L,Guardascione MA,Brancaccio V,et al.Coagulation disorders in liver disease[J].Semin Liver Dis,2002,22(1):83-96.
[16] Uemura M,Fujimura Y,Matsumoto M,et al.Comprehensive analysis of ADAMTS13 in patients with liver cirrhosis[J].Thromb Haemost,2008,99(6):1019-1029.
[17] Uemura M,Matsuyama T,Ishikawa M,et al.Decreased activity of plasma ADAMTS13 may contribute to the development of liver disturbance and multiorgan failure in patients with alcoholic hepatitis[J].Alcohol Clin Exp Res,2005,29(12 Suppl):264S-271S.
[18] Matsuyama T,Uemura M,Ishikawa M,et al.Increased von Willebrand factor over decreased ADAMTS13 activity may contribute to the development of liver disturbance and multiorgan failure in patients with alcoholic hepatitis[J].Alcohol Clin Exp Res,2007,(1 Suppl):S27-S35.
[19] Park YD,Yasui M,Yoshimoto T,et al.Changes in hemostatic parameters in hepatic veno-occlusive disease following bone marrow transplantation[J].Bone Marrow Transplant,1997,19(9):915-920.
[20] Matsumoto M,Kawa K,Uemura M,et al.Prophylactic fresh frozen plasma may prevent development of hepatic VOD after stem cell transplantation via ADAMTS13- mediated restoration of von Willebrand factor plasma levels[J].Bone Marrow Transplant,2007,40(3):251-259.
[21] Ko S,Okano E,Kanehiro H,et al.Plasma ADAMTS13 activity may predict early adverse events in living donor liver transplantation:observations in 3 cases [J].Liver Transpl,2006,12(5):859-869.
[22] Swisher KK,Doan JT,Vesely SK,et al.Pancreatitis preceding acute episodes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome:report of five patients with a systematic review of published reports[J].Haematologica,2007,92(7):936-943.
[23] Morioka C,Uemura M,Matsuyama T,et al.Plasma ADAMTS13 activity parallels the APACHEII score,reflecting an early prognostic indicator for patients with severe acute pancreatitis[J].Scand J Gastroenterol,2008,26(1):1-10.
[24] Kaikita K,Soejima K,Matsukawa M,et al.Reduced von Willebrand factor-cleaving protease(ADAMTS13) activity in acute myocardial infarction[J].J Thromb Haemost,2006,4(11):2490-2493.
[25] Manea M, Kristoffersson A, Schneppenheim R, et al.Podocytes express ADAMTS13 in normal renal cortex and in patients with thrombotic thrombocytopenic purpura[J].Br J Haematol,2007,138(4):651-662.
[26] Bockmeyer CL,Claus RA,Budde U,et al.Inflammation-associated ADAMTS13 deficiency promotes formation of ultra-large von Willebrand factor [J].Haematologica, 2008,93(1):137-140.
[27] Austin S,Cohen H,Losseff N.Haematology and neurology[J].J Neurol Neurosurg Psychiatry，2007,78(3):334-341.

相似文献/References: